Abbott Laboratories (ABT)

Add to Watchlists Create an Alert
37.48 -0.24  -0.64%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Abbott Laboratories R&D Expense Quarterly:

346.00M for Dec. 31, 2012
View Full Chart

Abbott Laboratories R&D Expense Quarterly Chart

    Abbott Laboratories Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 346.00M
    Dec. 31, 2012 1.141B
    Sept. 30, 2012 1.164B
    June 30, 2012 1.011B
    March 31, 2012 1.006B
    Dec. 31, 2011 1.152B
    Sept. 30, 2011 1.010B
    June 30, 2011 1.038B
    March 31, 2011 930.40M
    Dec. 31, 2010 1.057B
    Sept. 30, 2010 1.079B
    June 30, 2010 857.70M
    March 31, 2010 730.37M
    Dec. 31, 2009 917.05M
    Sept. 30, 2009 675.74M
    June 30, 2009 670.21M
    March 31, 2009 650.74M
    Dec. 31, 2008 731.63M
    Sept. 30, 2008 680.36M
    June 30, 2008 656.86M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ABT R&D Expense Quarterly Benchmarks

    Companies
    Johnson & Johnson 1.784B
    Pfizer 1.80B
    Eli Lilly and Company 1.348B

    ABT R&D Expense Quarterly Rankings

    Overall 99th percentile
    54 of 8009
    Sector 97th percentile
    16 of 687 in Healthcare
    Industry 97th percentile
    2 of 93 in Medical Devices

    ABT R&D Expense Quarterly Range, Past 5 Years

    Minimum 346.00M Mar 2013
    Maximum 1.164B Sep 2012
    Average 875.23M